[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615155":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":21,"centralContacts":26,"locations":36,"responsibleParty":52,"collaborators":21,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":21,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":21,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":21,"overallStatus":38,"whyStopped":21,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Peking Union Medical College Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Al18F-NOTA-LM3 and 68Ga-DOTATATE PET\u002FCT scan","EXPERIMENTAL","Patients will perform an Al18F-NOTA-LM3 PET\u002FCT as well as a 68Ga-DOTATATE PET\u002FCT scan within one week, with a minimum 24-hour interval between scans.",[13,14],"Drug: Diagnostic Test: Al18F-NOTA-LM3","Drug: Diagnostic Test: 68Ga-DOTATATE",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DRUG","Diagnostic Test: Al18F-NOTA-LM3","Patients will receive a single intravenous injection of Al18F-NOTA-LM3. Subsequently, a PET\u002FCT scan will be performed within 60 to 120 minutes post-injection.",[9],null,{"type":17,"name":23,"description":24,"armGroupLabels":25,"otherNames":21},"Diagnostic Test: 68Ga-DOTATATE","Patients will receive a single intravenous injection of 68Ga-DOTATATE. Subsequently, a PET\u002FCT scan will be performed within 40 to 60 minutes post-injection.",[9],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":21,"email":31},"Hongli Jing","CONTACT","18600586399","annsmile1976@sina.com",{"name":33,"role":29,"phone":34,"phoneExt":21,"email":35},"Yuwei Zhang","18511071577","ywzhangwork@163.com",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Beijing","Beijing Municipality","100730","China","CN",{"type":45,"coordinates":46},"Point",[47,48],116.39723,39.9075,{"lat":48,"lon":47},[51],{"name":28,"role":29,"phone":30,"phoneExt":21,"email":31},{"type":53,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100615155","al18f-nota-lm3-petct-in-patients-with-pheochromocytoma-and-paraganglioma-100615155",false,"NCT07288931","Al18F-NOTA-LM3 PET\u002FCT in Patients With Pheochromocytoma and Paraganglioma","A Comparative Study of Al18F-NOTA-LM3 Versus 68Ga-DOTATATE PET\u002FCT for Tumor Detection in Patients With Pheochromocytoma and Paraganglioma","Inclusion Criteria:\n\n* Patients aged 18 to 80 years.\n* Suspected or confirmed PPGL patients.\n\nExclusion Criteria:\n\n* Combined with other types of tumors.\n* Severe liver or renal dysfunction (ALT\u002FAST≥5 ULN, GFR\\\u003C30ml\u002Fmin).\n* Pregnant or breast-feeding women.\n* Inability to perform PET\u002FCT scans.","ALL","18 Years","80 Years",{"count":65,"type":66},40,"ESTIMATED","INTERVENTIONAL",[69],"NA","The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET\u002FCT and compare it with 68Ga-DOTATATE PET\u002FCT in patients with pheochromocytoma\u002Fparaganglioma (PPGL).",[72],"Pheochromocytoma\u002FParaganglioma (PPGL)","2025-12-04",{"date":75,"type":76},"2025-12-17","ACTUAL",{"date":78,"type":76},"2024-08-06",{"date":80,"type":66},"2026-03-01",{"name":5,"class":6},1]